The lack of guidance in pharmacological obesity care, therefore, highlights a critical gap and provides the rationale for exploring whether lessons from bariatric surgery can inform clinical practice in GLP-1 RAs users. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.